A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
- Status
- COMPLETED
- Phase
- PHASE3
Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- Status
- WITHDRAWN
- Phase
- N/A
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Impact of Liraglutide 3.0 on Body Fat Distribution
- Status
- COMPLETED
- Phase
- PHASE4
Saxenda in Obesity Services (STRIVE Study)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
Transformative Research in Diabetic Nephropathy
- Status
- RECRUITING
- Phase
- N/A
Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- Status
- COMPLETED
- Phase
- PHASE2
In-market Utilisation of Liraglutide Used for Weight Management in Europe
- Status
- COMPLETED
- Phase
- N/A
Long Term Survivors of High-grade Glioma and Their Caregivers
- Status
- COMPLETED
- Phase
- N/A